{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:22:29Z","timestamp":1786990949856,"version":"build-2736575974"},"reference-count":114,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017317","name":"Catholic Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijrobp.2024.10.034","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T02:38:25Z","timestamp":1730255905000},"page":"599-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Radiation Therapy for Meningiomas \u2013 Where Do We Stand and What's on the Horizon?"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6177-1755","authenticated-orcid":false,"given":"Felix","family":"Ehret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"El Baya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.","family":"Erridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bussi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost J.C.","family":"Verhoeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Niyazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Minniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen A.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1016\/j.ijrobp.2024.10.034_bib0001","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0002","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3171\/jns.1985.62.1.0018","article-title":"Meningioma: Analysis of recurrence and progression following neurosurgical resection","volume":"62","author":"Mirimanoff","year":"1985","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0003","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00006123-199908000-00003","article-title":"Proposed grading system to predict the extent of resection and outcomes for cranial base meningiomas","volume":"45","author":"Levine","year":"1999","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0004","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/neuonc\/noae082","article-title":"Meningioma: International Consortium on Meningiomas consensus review on scientific advances & treatment paradigms for clinicians, researchers, and patients","volume":"26","author":"Wang","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0005","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","article-title":"EANO guideline on the diagnosis and management of meningiomas","volume":"23","author":"Goldbrunner","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0006","unstructured":"National Comprehensive Cancer Network. Central nervous system cancers version 2.2024. 2024. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cns.pdf. Accessed June 9, 2024."},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0007","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.prro.2024.02.009","article-title":"A case-based guide for World Health Organization (WHO) grade 2 meningioma radiosurgery and radiation therapy from the radiosurgery society","volume":"14","author":"Vassantachart","year":"2024","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0008","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ijrobp.2024.04.016","article-title":"Salvage stereotactic radiosurgery for recurrent WHO grade 2 and 3 meningiomas: A multicenter study (STORM)","volume":"120","author":"Gallitto","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl 1","key":"10.1016\/j.ijrobp.2024.10.034_bib0009","first-page":"i67","article-title":"Radiotherapy and radiosurgery for meningiomas","volume":"5","author":"Chen","year":"2023","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11060-023-04407-2","article-title":"The evolving role of reirradiation in the management of recurrent brain tumors","volume":"164","author":"De Pietro","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.558845","article-title":"Proton therapy for intracranial meningioma for the treatment of primary\/recurrent disease including re-irradiation","volume":"10","author":"Weber","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0012","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11060-022-04171-9","article-title":"Radiotherapy for meningiomas","volume":"160","author":"Chen","year":"2022","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0013","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11060-022-04148-8","article-title":"Emerging systemic treatment options in meningioma","volume":"161","author":"Mair","year":"2023","journal-title":"J Neurooncol"},{"issue":"Supplement_9","key":"10.1016\/j.ijrobp.2024.10.034_bib0014","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1093\/neuonc\/noae069","article-title":"Radioligand therapies in meningioma - evidence and future directions","volume":"26","author":"Mair","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0015","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/neuonc\/nox112","article-title":"PET imaging in patients with meningioma-report of the RANO\/PET Group","volume":"19","author":"Galldiks","year":"2017","journal-title":"Neuro Oncol"},{"issue":"suppl 1","key":"10.1016\/j.ijrobp.2024.10.034_bib0016","first-page":"i84","article-title":"Advances in PET imaging for meningioma patients","volume":"5","author":"Galldiks","year":"2023","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0017","doi-asserted-by":"crossref","first-page":"e13015","DOI":"10.1111\/bpa.13015","article-title":"Use of advanced neuroimaging and artificial intelligence in meningiomas","volume":"32","author":"Galldiks","year":"2022","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0018","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<620::AID-IJC2>3.0.CO;2-S","article-title":"Expression of somatostatin receptor subtypes in human brain tumors","volume":"76","author":"Dutour","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0019","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.2217\/fon.14.139","article-title":"PET tracers for somatostatin receptor imaging of neuroendocrine tumors: Current status and review of the literature","volume":"10","author":"Johnbeck","year":"2014","journal-title":"Future Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0020","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00259-012-2155-3","article-title":"Detection of cranial meningiomas: Comparison of \u2076\u2078Ga-DOTATOC PET\/CT and contrast-enhanced MRI","volume":"39","author":"Afshar-Oromieh","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0021","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2967\/jnumed.114.149120","article-title":"Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue","volume":"56","author":"Rachinger","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0022","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clon.2013.10.001","article-title":"Controversies in radiotherapy for meningioma","volume":"26","author":"Maclean","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0023","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3171\/2012.6.JNS111987","article-title":"A radiopathological classification of dural tail sign of meningiomas","volume":"117","author":"Qi","year":"2012","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0024","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.crad.2004.01.019","article-title":"The dural tail sign\u2013beyond meningioma","volume":"60","author":"Guermazi","year":"2005","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0025","doi-asserted-by":"crossref","first-page":"9256","DOI":"10.1038\/s41598-022-13467-9","article-title":"Evaluating diagnostic accuracy and determining optimal diagnostic thresholds of different approaches to [68Ga]-DOTATATE PET\/MRI analysis in patients with meningioma","volume":"12","author":"Kim","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0026","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijrobp.2012.03.021","article-title":"Contribution of 68Ga-DOTATOC PET\/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy","volume":"85","author":"Graf","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0027","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijrobp.2005.12.006","article-title":"Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET","volume":"65","author":"Milker-Zabel","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0028","first-page":"vdab012","article-title":"[68Ga]-DOTATATE PET\/MRI as an adjunct imaging modality for radiation treatment planning of meningiomas","volume":"3","author":"Mahase","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0029","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00259-009-1270-2","article-title":"Potential impact of (68)Ga-DOTATOC PET\/CT on stereotactic radiotherapy planning of meningiomas","volume":"37","author":"Nyuyki","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1748-717X-4-56","article-title":"[68Ga]-DOTATOC-PET\/CT for meningioma IMRT treatment planning","volume":"4","author":"Gehler","year":"2009","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0031","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ijrobp.2022.04.009","article-title":"68Ga-DOTATATE PET-based radiation contouring creates more precise radiation volumes for patients with meningioma","volume":"113","author":"Perlow","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0032","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13014-021-01875-6","article-title":"68Ga-DOTATATE PET-CT as a tool for radiation planning and evaluating treatment responses in the clinical management of meningiomas","volume":"16","author":"Kowalski","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0033","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00259-019-04591-2","article-title":"Integration of PET-imaging into radiotherapy treatment planning for low-grade meningiomas improves outcome","volume":"47","author":"Kessel","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0034","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ijrobp.2023.10.014","article-title":"A prospective registry study of 68Ga-DOTATATE PET\/CT incorporation into treatment planning of intracranial meningiomas","volume":"118","author":"Perlow","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0035","first-page":"vdab114","article-title":"Multimodal therapy of cavernous sinus meningioma: Impact of surgery and 68Ga-DOTATATE PET-guided radiation therapy on tumor control and functional outcome","volume":"3","author":"Hadi","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0036","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00259-023-06400-3","article-title":"Postoperative [(68)Ga]Ga-DOTA-TATE PET\/CT imaging is prognostic for progression-free survival in meningioma WHO grade 1","volume":"51","author":"Teske","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0037","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/neuonc\/noae067","article-title":"[Ga68] DOTATATE PET\/MRI-guided radiosurgical treatment planning and response assessment in meningiomas","volume":"26","author":"Ivanidze","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0038","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1007\/s00259-024-06783-x","article-title":"Joint EANM\/EANO\/RANO\/SNMMI practice guideline\/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: Version 1.0","volume":"51","author":"Albert","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0039","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ijrobp.2022.04.041","article-title":"68Ga-DOTATATE PET: The future of meningioma treatment","volume":"113","author":"Prasad","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0040","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1038\/s41596-020-00407-y","article-title":"Radiosynthesis of [(18)F]SiFAlin-TATE for clinical neuroendocrine tumor positron emission tomography","volume":"15","author":"Lindner","year":"2020","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0041","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/RLU.0000000000003607","article-title":"PET Imaging of meningioma using the novel SSTR-targeting peptide 18F-SiTATE","volume":"46","author":"Unterrainer","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0042","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s00259-020-04704-2","article-title":"In vivo imaging of cell proliferation in meningioma using \u2018-deoxy-3\u2019-[18F]fluorothymidine PET\/MRI","volume":"47","author":"Bashir","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0043","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijrobp.2006.02.047","article-title":"11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy","volume":"66","author":"Grosu","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0044","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ijrobp.2008.02.058","article-title":"Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas","volume":"72","author":"Astner","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0045","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1093\/brain\/awaa267","article-title":"PET imaging of meningioma with 18F-FLT: A predictor of tumour progression","volume":"143","author":"Bashir","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0046","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190237","article-title":"Proton therapy for brain tumours in the area of evidence-based medicine","volume":"93","author":"Weber","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0047","doi-asserted-by":"crossref","first-page":"e27046","DOI":"10.1002\/pbc.27046","article-title":"Proton therapy for central nervous system tumors in children","volume":"65","author":"Ladra","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0048","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13014-017-0924-7","article-title":"Treatment of meningioma and glioma with protons and carbon ions","volume":"12","author":"Adeberg","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0049","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrclinonc.2017.30","article-title":"Charged-particle therapy in cancer: Clinical uses and future perspectives","volume":"14","author":"Durante","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"suppl 2","key":"10.1016\/j.ijrobp.2024.10.034_bib0050","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1093\/neuonc\/noad183","article-title":"How proton therapy fits into the management of adult intracranial tumors","volume":"26","author":"Kotecha","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0051","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/j.ijrobp.2011.10.056","article-title":"Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma","volume":"83","author":"Arvold","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0052","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.ijrobp.2004.06.212","article-title":"Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions","volume":"60","author":"Baumert","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0053","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clon.2018.01.006","article-title":"Clinical indications for carbon ion radiotherapy","volume":"30","author":"Mohamad","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0054","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.3390\/cancers15123099","article-title":"Long term outcome and quality of life of intracranial meningioma patients treated with pencil beam scanning proton therapy","volume":"15","author":"Krcek","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nec.2023.02.013","article-title":"The role of radiotherapy in the treatment of higher-grade meningioma","volume":"34","author":"Lee","year":"2023","journal-title":"Neurosurg Clin N Am"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0056","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2019.3.FOCUS1967","article-title":"Efficacy and toxicity of particle radiotherapy in WHO grade II and grade III meningiomas: A systematic review","volume":"46","author":"Wu","year":"2019","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0057","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/neuonc\/noad244","article-title":"Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trial","volume":"26","author":"Deng","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0058","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","article-title":"The recurrence of intracranial meningiomas after surgical treatment","volume":"20","author":"Simpson","year":"1957","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0059","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ijrobp.2019.11.028","article-title":"High-risk meningioma: Initial outcomes from NRG oncology\/RTOG 0539","volume":"106","author":"Rogers","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0060","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: Definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0061","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1080\/0284186X.2023.2241994","article-title":"Proton therapy re-irradiation provides promising clinical results in recurrent brain meningioma","volume":"62","author":"Scartoni","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0062","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13014-018-1026-x","article-title":"Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma","volume":"13","author":"El Shafie","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0063","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s11864-023-01131-x","article-title":"Mitigating radiotoxicity in the central nervous system: Role of proton therapy","volume":"24","author":"Winter","year":"2023","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0064","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/neuonc\/noz048","article-title":"Treatment-induced brain tissue necrosis: A clinical challenge in neuro-oncology","volume":"21","author":"Winter","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijrobp.2021.08.015","article-title":"Mechanisms and review of clinical evidence of variations in relative biological effectiveness in proton therapy","volume":"112","author":"Paganetti","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0066","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1158\/1078-0432.CCR-24-1215","article-title":"Decoding patient heterogeneity influencing radiation-induced brain necrosis","volume":"30","author":"Chamseddine","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0067","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/pro6.1149","article-title":"A review of proton therapy - current status and future directions","volume":"6","author":"Mohan","year":"2022","journal-title":"Precis Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0068","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/cncr.29882","article-title":"A systematic review of the cost and cost-effectiveness studies of proton radiotherapy","volume":"122","author":"Verma","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0069","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ijrobp.2017.07.008","article-title":"Prospective, randomized study of radiation dose escalation with combined proton-photon therapy for benign meningiomas","volume":"99","author":"Sanford","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1227\/NEU.0b013e31822d408a","article-title":"Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients","volume":"70","author":"Santacroce","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0071","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijrobp.2022.08.064","article-title":"Hypofractionated radiosurgery for large or in critical-site intracranial meningioma: Results of a phase 2 prospective study","volume":"115","author":"Pinzi","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0072","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.radonc.2018.06.018","article-title":"Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042)","volume":"128","author":"Weber","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0073","article-title":"Effectiveness of postoperative adjuvant radiotherapy in atypical meningioma patients after gross total resection: A meta-analysis study","volume":"10","author":"He","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0074","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/neuonc\/nou025","article-title":"Adjuvant radiotherapy for atypical and malignant meningiomas: A systematic review","volume":"16","author":"Kaur","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0075","first-page":"115","article-title":"Radiotherapy intensification for atypical and malignant meningiomas: A systematic review","volume":"11","author":"Gaito","year":"2024","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0076","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11060-022-04206-1","article-title":"Dose-response relationship in patients with newly diagnosed atypical meningioma treated with adjuvant radiotherapy","volume":"161","author":"Kim","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0077","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ijrobp.2023.09.026","article-title":"Dose-escalated radiation therapy is associated with improved outcomes for high-grade meningioma","volume":"118","author":"Zeng","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0078","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11060-022-04107-3","article-title":"The \u201cCombo\u201d radiotherapy treatment for high-risk grade 2 meningiomas: Dose escalation and initial safety and efficacy analysis","volume":"161","author":"Pontoriero","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0079","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0081","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11060-022-04228-9","article-title":"Molecular classification and grading of meningioma","volume":"161","author":"Nasrallah","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0082","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: A multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0083","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","article-title":"A clinically applicable integrative molecular classification of meningiomas","volume":"597","author":"Nassiri","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0084","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","article-title":"Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities","volume":"54","author":"Choudhury","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0085","doi-asserted-by":"crossref","first-page":"eabm6247","DOI":"10.1126\/sciadv.abm6247","article-title":"Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies","volume":"8","author":"Bayley","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0086","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1200\/JCO.21.00784","article-title":"Integrated molecular-morphologic meningioma classification: A multicenter retrospective analysis, retrospectively and prospectively validated","volume":"39","author":"Maas","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0087","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/neuonc\/noab213","article-title":"A molecularly integrated grade for meningioma","volume":"24","author":"Driver","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0088","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/s41591-023-02586-z","article-title":"Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses","volume":"29","author":"Chen","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0089","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00401-023-02642-5","article-title":"Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: Comprehensive molecular analysis of EORTC 22042-26042","volume":"146","author":"Maas","year":"2023","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-024-01739-6","article-title":"Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas","volume":"12","author":"Ehret","year":"2024","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0091","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/neuonc\/noac137","article-title":"Low-risk meningioma: Initial outcomes from NRG Oncology\/RTOG 0539","volume":"25","author":"Rogers","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0092","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3171\/2016.11.JNS161170","article-title":"Intermediate-risk meningioma: Initial outcomes from NRG Oncology RTOG 0539","volume":"129","author":"Rogers","year":"2018","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0093","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1038\/s41591-024-03167-4","article-title":"Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma","volume":"30","author":"Wang","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0094","first-page":"noae170","article-title":"cIMPACT-NOW Update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas","author":"Sahm","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0095","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/neuonc\/noac206","article-title":"Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas","volume":"25","author":"Youngblood","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0096","first-page":"vdab148","article-title":"Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax","volume":"3","author":"Yamamoto","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0097","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.18632\/oncotarget.3692","article-title":"Valproic acid promotes radiosensitization in meningioma stem-like cells","volume":"6","author":"Chiou","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0098","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.canlet.2017.11.035","article-title":"LB-100, a novel protein phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation","volume":"415","author":"Ho","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0099","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13014-021-01918-y","article-title":"Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma","volume":"16","author":"Degorre","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0100","first-page":"268","article-title":"Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma","volume":"7","author":"Mathen","year":"2020","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0101","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/S1470-2045(18)30096-2","article-title":"Combining precision radiotherapy with molecular targeting and immunomodulatory agents: A guideline by the American Society for Radiation Oncology","volume":"19","author":"Bristow","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0102","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/s41467-022-29052-7","article-title":"Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas","volume":"13","author":"Brastianos","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0103","article-title":"Mismatch repair deficiency in high-grade meningioma: A rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade","volume":"2","author":"Dunn","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0104","first-page":"vdae092","article-title":"Response to immune checkpoint inhibition in a meningioma with DNA mismatch repair deficiency","volume":"6","author":"Nguyen","year":"2024","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-3-031-29750-2_12","article-title":"Radiation-induced meningiomas","volume":"1416","author":"Wang","year":"2023","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0106","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-019-02029-5","article-title":"An update on the CNS manifestations of neurofibromatosis type 2","volume":"139","author":"Coy","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0107","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/FOC\/2008\/24\/5\/E7","article-title":"Radiation-induced meningioma","volume":"24","author":"Umansky","year":"2008","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0108","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3171\/2020.7.JNS202064","article-title":"Stereotactic radiosurgery for treatment of radiation-induced meningiomas: A multiinstitutional study","volume":"135","author":"Bunevicius","year":"2021","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0109","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11060-020-03515-7","article-title":"Efficacy of stereotactic radiosurgery for radiation-induced meningiomas","volume":"148","author":"Huo","year":"2020","journal-title":"J Neurooncol"},{"issue":"suppl","key":"10.1016\/j.ijrobp.2024.10.034_bib0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3171\/2014.7.GKS141311","article-title":"Malignant transformation in vestibular schwannoma: Report of a single case, literature search, and debate","volume":"121","author":"Seferis","year":"2014","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0111","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3171\/2020.12.JNS202814","article-title":"Neurofibromatosis type 2-associated meningiomas: An international multicenter study of outcomes after Gamma Knife stereotactic radiosurgery","volume":"136","author":"Mohammed","year":"2022","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0112","first-page":"vdad025","article-title":"Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy\/malignant progression","volume":"5","author":"Evans","year":"2023","journal-title":"Neurooncol Adv"},{"issue":"suppl 1","key":"10.1016\/j.ijrobp.2024.10.034_bib0113","first-page":"i94","article-title":"The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis","volume":"5","author":"Gregory","year":"2023","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.ijrobp.2024.10.034_bib0114","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/neuonc\/nos129","article-title":"Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: Clinical, radiological, and molecular features","volume":"14","author":"Goutagny","year":"2012","journal-title":"Neuro Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624035259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624035259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:51:31Z","timestamp":1781193091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624035259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":114,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0360301624035259"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.10.034","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy for Meningiomas \u2013 Where Do We Stand and What's on the Horizon?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}